Provost Steven E. Hyman confirmed plans were in progress for the Harvard Stem Cell Center, which would bring together researchers from the University and affiliated hospitals who are already exploring the promising cells’ potential to help cure diseases like AIDS and diabetes.
“We are moving forward on a stem cell center,” Hyman said. “It’s something Harvard ought to be doing. It is something we can be preeminent in.”
The revelation, first reported yesterday in The Boston Globe, comes two weeks after a South Korean laboratory became the first to extract a line of stem cells from a cloned human embryo, disappointing Harvard researchers who had been pursuing the achievement.
A report circulated by Dean of the Faculty of Arts and Sciences (FAS) William C. Kirby in January included a proposal to establish a stem cell research program on the University’s lands in Allston.
“Not only does the Institute propose to bridge the gap from basic to applied life science, it also proposes to address the complex social, ethical and religious questions that have arisen as stem cell research has advanced,” read the report obtained by The Crimson.
Human embryonic stem cells, which can harness the potency of fertilized eggs to form any variety of human tissue, have emerged as a pivotal—and controversial—field of study.
Bush administration restrictions limit government-financed research to pre-existing stem cells, but Hyman said the University would seek funding for the center from private donors and foundations.
The January report said 20 faculty would be required for the effort, including five new recruitments. Hyman would not confirm those numbers yesterday but said additional hirings were a possibility.
According to the report, the research program would link the work of scientists currently working on stem cells at FAS, Harvard Medical School (HMS) and Harvard hospitals.
The report says that the center will focus initially on four “disease areas”: blood diseases including AIDS, diabetes, neurodegenerative diseases and cardiovascular diseases.
The center will initially exist without a home, said Associate Professor of Medicine David T. Scadden, who will co-direct the program, but a physical presence is on the agenda.
“Ultimately, we do think it would be best if we did have a physical space where there was a core group of researchers that were working together,” Scadden said.
According to the report, the proposed stem cell center would include new lab facilities for researchers and an “administrative infrastructure to support the work.”
After the breakthrough in South Korea last month, Scadden said Harvard needed to redouble its efforts in stem cell research.
“It’s a terrible disappointment that we’re reading about it from other countries,” Scadden said in early February. “It’s imperative that we be able to use this technology in the U.S.”